CoChat
Sign Up
Cited by 30

The DOI matches its Crossref record.

Regulation of corticotropin‐releasing hormone receptor‐2 expression in human cord blood‐derived cultured mast cells

Papadopoulou, Nikoletta G, Oleson, Lauren, Kempuraj, Duraisamy, Donelan, Jill, Cetrulo, Curtis L, Theoharides, Theoharis C·2005·Journal of Molecular Endocrinology
DOI 10.1677/jme.1.01833
Open this paper in CoChat — free account

Abstract

Corticotropin-releasing hormone (CRH) is secreted under stress and regulates the hypothalamic-pituitary-adrenal (HPA) axis; it is also secreted outside the brain where it exerts proinflammatory effects, possibly through mast cell activation. Mast cells are necessary for allergic reactions, but are increasingly implicated in acquired immunity and inflammatory diseases worsened by stress. Acute stress and intradermal CRH induced murine skin mast cell activation and increased vascular permeability that was absent in W/Wv mast cell deficient mice. The presence of functional CRH receptors (CRH-R) was recently reported on human mast cells. Here, we studied the expression of CRH-R1 and CRH-R2 by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and fluorescent immunocytochemistry in human umbilical cord blood-derived cultured mast cells (hCBMCs) treated with Interleukin (IL)-1, IL-4 or lipopolysaccharide (LPS). Ten week-old hCBMCs cultured in the presence of Stem cell factor (SCF) and IL-6 were positive for both CRH-R1 and CRH-R2. However, the expression of only CRH-R2 mRNA and protein was induced by priming hCBMCs with IL-4 for the last three weeks of culture. Further analysis of the CR-H R2 mRNA expression showed that addition of IL-1 or LPS for 6 h increased only CRH-R2 gene expression. CRH had negligible effect on IL-6 secretion from non-primed hCBMCs, but induced release from IL-4 primed cells. Interestingly, LPS alone increased IL-6 release in non-primed cells, but lost this effect in primed cells. These results further implicate mast cells and CRH in either initiating or potentiating inflammatory diseases, especially those affected by stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1677/jme.1.01833

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. Agelaki S , Tsatsanis C, Gravanis A & Margioris AN 2002 Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infections & Immunology706068–6074. · DOI
  2. Audhya T , Jain R & Hollander CS 1991 Receptor-mediated immunomodulation by corticotropin-releasing factor. Cell Immunology13477–84. · DOI
  3. Bischoff SC , Sellge G, Lorentz A, Sebald W, Raab R & Manns MP 1999 IL-4 enhances proliferation and mediator release in mature human mast cells. PNAS968080–8085. · DOI
  4. Cao J , Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL & Theoharides TC 2005 Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor (VEGF). Journal of Immunology1747665–7675. · DOI · Paper page
  5. Chen AM , Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, Lewis KA, Rivier JE, Sawchenko PE & Vale WW 2005 A soluble mouse brain splice variant of type 2 alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. PNAS1022620–2625. · DOI
  6. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine3321351–1362.
  7. Coste SC , Heldwein KA, Stevens SL, Tobar-Dupres E & Stenzel-Poore M 2001 IL-1 alpha and TNF alpha down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology1423537–3545. · DOI
  8. Esposito P , Chandler N, Kandere-Grzybowska K, Basu S, Jacobson S, Connolly R, Tutor D & Theoharides TC 2002 Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. Journal of Pharmacology & Experimental Therapy3031061–1066. · DOI · Paper page
  9. Florio P , Franchini A, Reis FM, Pezzani I, Ottaviani E & Petraglia F 2000 Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. Placenta2132–37. · DOI
  10. Huang M , Pang X, Karalis K & Theoharides TC 2003 Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. Cardiovascular Research59241–249. · DOI · Paper page
  11. Kandere-Grzybowska K , Letourneau R, Boucher W, Bery J, Kempuraj D, Poplawski S, Athanassiou A & Theoharides TC 2003 IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. Journal of Immunology1714830–4836. · DOI
  12. Karalis K , Sano H, Redwine J, Listwak S, Wilder RL & Chrousos GP 1991 Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science254421–423. · DOI
  13. Katsarou-Katsari A , Singh LK & Theoharides TC 2001 Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology203157–161. · DOI
  14. Kempuraj D , Saito H, Kaneko A, Fukagawa K, Nakayama M, Toru H, Tomikawa M, Tachimoto H, Ebisawa M, Akasawa A et al.1999 Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood933338–3346. · DOI
  15. Kempuraj D , Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A & Theoharides TC 2004 Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology14543–48. · DOI
  16. Kobayashi H , Ishizuka T & Okayama Y 2000 Human mast cells and basophils as sources of cytokines. Clinical Experiments in Allergy301205–1212. · DOI
  17. Leal-Berumen I , Conlon P & Marshall JS 1994 IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. Journal of Immunology1525468–5476. · DOI
  18. Liaw CW , Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE & De Souza EB 1996 Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology13772–77. · DOI
  19. Marone G , Galli SJ & Kitamura Y 2002 Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease. Trends in Immunology23425–427. · DOI
  20. McCurdy JD , Olynych TJ, Maher LH & Marshall JS 2003 Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. Journal of Immunology1701625–1629. · DOI
  21. McEvoy AN , Bresnihan B, FitzGerald O & Murphy EP 2001 Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1α corticotropin-releasing hormone receptor. Arthritis & Rheumatitis441761–1767. · DOI
  22. Mei-Tal V , Meyerowitz S & Engel GL 1970 The role of psychological process in a somatic disorder: multiple sclerosis. 1. The emotional setting of illness onset and exacerbation. Psychosomatic Medicine3267–86. · DOI
  23. Mousa SA , Bopaiah CP, Stein C & Schafer M 2003 Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain106297–307. · DOI
  24. Okumura S , Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H & Okayama Y 2003 Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood1022547–2554. · DOI
  25. Papadopoulou N , Kalogeromitros D, Staurianeas NG & Theoharides TC 2005 Corticotroopin-releasing hormone receptor-1 and histidine decarboxylase overespression in inflammatory skin disease. Journal of Investigative Dermatology, in press. · DOI
  26. Pisarchik A & Slominski A 2001 Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variatns and their differential expression. FASEB Journal152754–2756. · DOI
  27. Pisarchik A & Slominski A 2004 Molecular and functional characterization of novel CRFR1 isoforms from the skin. European Journal of Biochemistry2712821–2830. · DOI
  28. Puxeddu I , Piliponsky AM, Bachelet I & Levi-Schaffer F 2003 Mast cells in allergy and beyond. International Journal of Biochemistry & Cell Biology351601–1607. · DOI
  29. Slominski A , Pisarchik A, Tobin DJ, Mazurkiewicz J & Wortsman J 2004 Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology145941–950. · DOI
  30. Snapper CM , Pecanha LM, Levine AD & Mond JJ 1991 IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. Journal of Immunology1471163–1170. · DOI
  31. Spiegelberg HL 2005 Fc receptors for IgE and interleukin-4 induced IgE and IgG4 secretion. Journal of Investigative Dermatology9449S–52S.
  32. Theoharides TC & Cochrane DE 2004 Critical role of mast cells in inflammatory diseases and the effect of acute stress. Journal of Neuroimmunology1461–12. · DOI
  33. Theoharides TC , Spanos CP, Pang X, Alferes L, Ligris K, Letourneau R, Rozniecki JJ, Webster E & Chrousos G 1995 Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology1365745–5750. · DOI · Paper page
  34. Theoharides TC , Singh LK, Boucher W, Pang X, Letourneau R, Webster E & Chrousos G 1998 Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology139403–413. · DOI
  35. Theoharides TC , Donelan JM, Papadopoulou N, Cao J, Kempuraj D & Conti P 2004 Mast cells as targets of corticotropin-releasing factor and related peptides. Trends in Pharmacological Science25563–568. · DOI
  36. Toru H , Eguchi M, Matsumoto R, Yanagida M, Yata J & Nakahata T 1998 Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood91187–195. · DOI
  37. van der Kleij HP , Ma D, Redegeld FA, Kraneveld AD, Nijkamp FP & Bienenstock J 2003 Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. Journal of Immunology1712074–2079. · DOI
  38. Varadaradjalou S , Feger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M & Arock M 2003 Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. European Journal of Immunology33899–906. · DOI
  39. Webster EL , Tracey DE, Jutila MA, Wolfe SA, Jr. & DeSouza EB 1990 Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages. Endocrinology127440–452. · DOI
  40. Wosinska-Becler K , Plewako H, Hakansson L & Rak S 2004 Cytokine production in peripheral blood cells during and outside the pollen season in birch-allergic patients and non-allergic controls. Clinical & Experimental Allergy34123–130. · DOI

Cited by

Sorted by citations

Metadata

Authors
Papadopoulou, N. G., Oleson, L., Kempuraj, D., Donelan, J., Cetrulo, C. L., & Theoharides, T. C.
Affiliations
  • Departments of Pharmacology and Experimental Therapeutics, 1
  • Department of Obstetrics and Gynecology, Tufts-New England Medical Center, Boston, MA 02111, USA 4
Venue
Journal of Molecular Endocrinology
Publisher
Bioscientifica
Published
2005-12-01
Volume
35
Issue
3
Pages
R1-R8
ISSN
  • 1479-6813
  • 0952-5041
DOI
10.1677/jme.1.01833
Cited by
30
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review